This Event Has Now Run
In the context of dramatically increasing food allergy incidence and a breakthrough approval in the field, the Next Generation Food Allergy Drug Development Summit united large pharma and innovative biotechs to overcome the unique drug development challenges involved in turning promising food allergy biologics into clinical and commercial realities.
The 2021 meeting investigated the latest technological innovations, helped attendees benchmark against peers, build global connections, and streamline their drug development pipelines for food allergy. Insights from a range of companies and institutions including Aimmune, Camallergy, Allergy Therapeutics, Intrommune, Vedanta Biosciences and the University of North Carolina were also shared.
View the 2021 event guide to learn more.
2021 Attending Companies Included:
2021 Industry-Leading Speakers Included:
Professor, Pediatric Allergy
Kings College London
Principal Scientist, Innovation & Product Development
Co-Founder & CSO